FLT1 and cancer: Specifically, VEGFR1 is more characteristic under pathological conditions, including inflammation and cancer, whereas VEGFR2 signaling appears to be more focused on the regulation of vascular endothelial cell proliferation and permeabilization, as well as survival signaling pathways [151,152].